Age: 63 · Location: UK · Frame: chair (Foresight house-chair) · Judge tier: 1b · Judge Focus-44 rank: 10
Chair (portfolio: Clearview Medtech 14605109 [conflict], HTSL Group, Mole Clinic, BVL Topco)
_Company: Multiple boards; Foresight house-chair._
Chaired HSL 2015-25 through the buy-in, 8 bolt-ons and the Asker exit (2.5-8.5x for Foresight); ex-CEO Asteral (Fast Track 100).
Chaired HSL 2015-25 through the buy-in + 8 bolt-ons + Asker exit (2.5-8.5x for Foresight); ex-CEO Asteral; MD Dixons Stores + CEO Jessops PLC (pre-2011 confirmed).
HSL Foresight exit 2025 up to 8.5x return, 30→175 employees, revenues 7x to ~£60m (Lin 44-walk).
AVAILABLE_NOW for new chair roles
Outreach window: APPROACH NOW (with Clearview scope decision)
Foresight network; approach only after deciding whether Clearview Medtech (endoscope-servicing) niche is in scope
chair (Foresight house-chair) · UK PE-portfolio chair pattern · L4 bracket ADJACENT · L1=3 L2=4 L4=4 L5=5 L6=4
Path to seat: portfolio_chair_ex_operator
Data gap: Real conflict: Chair Clearview Medtech 14605109 (endoscope servicing) — decide scope before approach
Data gap: L6 revised: age 63 no longer mechanically scored; actively taking new chair roles = strong forward motivation signal.
Data gap: L6 evidence-only rescore: Actively taking new chair roles 2025-26 (BVL Topco Dec-2025) = active portfolio-chair phase